Updates are available Correction dated 2024-08-13
Click to view Correction: https://doi.org/10.1007/s40121-024-01030-0
-
Authors
Katsube, Takayuki https://orcid.org/0000-0001-9569-716X
Kezbor, Safwan
Shimizu, Ryosuke
Kubota, Ryuji
-
Funding
Funding for this research was provided by:
Shionogi
- License Information
-
More Information
Article History
Received: 24 January 2024
Accepted: 20 February 2024
First Online: 9 March 2024
Change Date: 13 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-024-01030-0
Declarations
:
: Takayuki Katsube, Ryosuke Shimizu, and Ryuji Kubota are employees of Shionogi & Co., Ltd. Kezbor Safwan is an employee of Shionogi Inc.
: This study (NCT05363215) was conducted in accordance with the protocol. The study protocol was approved by the Declaration of Helsinki and Council for International Organizations of Medical Sciences International Ethical Guidelines, the Institutional Review Board, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice Guidelines, and other regulations and applicable laws. The Institutional Review Board also approved the study. All participants in this study gave their written informed consent for participation [ – ].
